Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Acute myeloid leukaemia (AML), Blood cancers, Chronic leukaemia, Chronic myeloid leukaemia (CML), Myelodysplastic syndrome (MDS)
Closed
Phase 2
This study is looking at a type of treatment called intestinal microbiota transplant. It’s a way of encouraging more variety in gut bacteria.
It’s open to people having a with donor cells for:
acute myeloid leukaemia (AML)
acute lymphoid leukaemia (ALL)
acute leukaemia of ambiguous lineage
myelodysplastic syndrome (MDS)
chronic myelomonocytic leukaemia (CMML)
chronic myeloid leukaemia (CML)
Recruitment start: 1 May 2024
Recruitment end: 28 November 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Jiri Pavlu
Professor Julian Marchesi
Imperial College London
Medical Research Council (MRC)
Last reviewed: 28 Nov 2025
CRUK internal database number: 19681